msokolova_rheum Profile Banner
Maria Sokolova, MD PhD Profile
Maria Sokolova, MD PhD

@msokolova_rheum

Followers
720
Following
4K
Statuses
1K

Rheumatology resident at @UKSH_KI_HL, @eular_org-@EMEUNET. Alumnus @MoscowStateuniv @uniFAU. ACPA specialist; rheumatoid Arthritis, Psoriatic Arthritis 🫶🏻

Germany
Joined October 2009
Don't wanna be here? Send us removal request.
@msokolova_rheum
Maria Sokolova, MD PhD
2 years
Now it is out there! 🥳 IgA #ACPA are associated with the development of RA, and their levels decline at disease onset, which is yet another indicator that barriers are major players + I gathered more data since the submission which go the same direction
1
0
19
@msokolova_rheum
Maria Sokolova, MD PhD
4 days
Super cool thread 👍🏻
@deepti_pramod
Deepti Agarwal
6 days
Never Lose Hope! Lessons from CD20 depletion Ritux (LUNAR) : Failed Obinitizumab : NOBILITY (Phase II) and REGENCY (Phase III): Success The now available REGENCY speaks volumes on why science evolves. What fails today may succeed tomorrow! #LupusNephritis #Rheumtwitter (1/3)
Tweet media one
0
1
4
@msokolova_rheum
Maria Sokolova, MD PhD
4 days
RT @AdelaCastro222: Pearls on Dermatomyositis: -Negative myomarker does not r/o DM -Pruritus can be a skin manifestation in DM🚨 -Combinatio…
0
49
0
@msokolova_rheum
Maria Sokolova, MD PhD
3 months
RT @drdavidliew: Should you worry about giving TNFi to RA pts after a cancer diagnosis? Medicare data with colorectal, lung, prostate Ca:…
0
39
0
@msokolova_rheum
Maria Sokolova, MD PhD
3 months
RT @AdelaCastro222: “Small fiber neuropathy is an extremely common finding in hundreds of medical conditions-most of which are not involvin…
0
34
0
@msokolova_rheum
Maria Sokolova, MD PhD
3 months
0
1
0
@msokolova_rheum
Maria Sokolova, MD PhD
3 months
RT @RheumNow: FDA has given FDA Breakthrough Therapy designation to Nipocalimab for treatment of adults w/ moderate-to-severe Sjögren’s dis…
0
48
0
@msokolova_rheum
Maria Sokolova, MD PhD
3 months
0
0
2
@msokolova_rheum
Maria Sokolova, MD PhD
4 months
RT @AlexStibi: Really useful review article on noninfectious #aortitis, the many possible groups of etiologies, their work-up and the need…
0
12
0
@msokolova_rheum
Maria Sokolova, MD PhD
5 months
A cool insight from Prof. Baraliakos on the difference of acute and chronic lesions in #spa - the former being primarily osteoclasts, the latter osteoblasts. #dgrh2024
Tweet media one
0
0
2
@msokolova_rheum
Maria Sokolova, MD PhD
5 months
We should always think about #CPPD prior to diagnosing seronegative #rheumatoidarthritis ⬇️
0
0
1
@msokolova_rheum
Maria Sokolova, MD PhD
5 months
RT @javierrcarrio: Please help us by contributing and disseminating among your networks, institutions and colleagues @eular_org @EMEUNET @…
0
10
0
@msokolova_rheum
Maria Sokolova, MD PhD
5 months
Happy to take a break from emergency medicine and be in the world of rheumatology again in Düsseldorf 🫶🏻#dgrh2024
Tweet media one
0
0
17
@msokolova_rheum
Maria Sokolova, MD PhD
5 months
New Research from the north sheds light on why we are no closer to the “cure” of the rheumatic diseases yet
@medinflame
PMI
5 months
Autoantigen-specific immune cells escape therapy due to "exhausted" state: @UKSH_KI_HL @kieluni #inflammation #precisionmedicine
0
0
2
@msokolova_rheum
Maria Sokolova, MD PhD
5 months
RT @JAMA_current: Take the JAMA Clinical Challenge A 51-year-old woman presented with a 1-month history of intense and worsening polyarthr…
0
3
0
@msokolova_rheum
Maria Sokolova, MD PhD
6 months
RT @RheumNow: Immune pathology of bursitis in rheumatic conditions - role of inflammation, degeneration, & mechanical stress. Cells and cyt…
0
8
0
@msokolova_rheum
Maria Sokolova, MD PhD
6 months
RT @EMEUNET: Did you check out the latest #EMEUNEWS with all #EULAR2024 Highlights? These are our #SLE and #APS highlights! Selected by @c
0
10
0
@msokolova_rheum
Maria Sokolova, MD PhD
7 months
RT @ARD_BMJ: ☝️ #anti-IL17F/A #bimekizumab may protect from #uveitis in #axSpA✔️ ◻️ 349 patients in phase 2b/3 trials 👉uveitis: 0.6% wit…
0
33
0
@msokolova_rheum
Maria Sokolova, MD PhD
7 months
RT @RheumNow: Review of Amyloidosis The New England Journal of Medicine has published a review of systemic amyloidosis.
0
15
0
@msokolova_rheum
Maria Sokolova, MD PhD
8 months
RT @reinmd77: 54yo♀️3mths📈polyarthritis EMS1h ROS✔️ ESR CRP⬆️ Xray✔️ "Sero-RA" Pred MTX 3mths🚫 2x anti-TNF9mths🚫 🆕paraprot/free κ light cha…
0
7
0
@msokolova_rheum
Maria Sokolova, MD PhD
8 months
RT @drdavidliew: Periodontal disease is a major factor in the development of RA - and that’s the tooth! in ACPA+ clinically suspect arthra…
0
13
0